---
title: "Gilead to report Q2 2026 results after market close, host webcast update"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293380456.md"
description: "Gilead Sciences will release its Q2 2026 financial results and guidance on August 4, 2026, after market close. Management will host a webcast at 4:30 p.m. ET to discuss the results and provide a business update. The live webcast will be available via the Investors section of Gilead's website."
datetime: "2026-07-21T20:05:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293380456.md)
  - [en](https://longbridge.com/en/news/293380456.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293380456.md)
generator: "portal-rs"
---

# Gilead to report Q2 2026 results after market close, host webcast update

-   Gilead will release second-quarter 2026 financial results, including guidance, on Aug. 4, 2026. \* Management will host a webcast at 4:30 p.m. ET on Aug. 4, 2026 to discuss results, guidance, and a business update. \* Live webcast available via the Investors section of here. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607211605BIZWIRE\_USPR\_\_\_\_\_20260721\_BW606848) on July 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [GIS.DE](https://longbridge.com/en/quote/GIS.DE.md)

## Related News & Research

- [New HIV and Breast Cancer Wins Might Change The Case For Investing In Gilead Sciences (GILD)](https://longbridge.com/en/news/297483843.md)
- [FDA Approves Gilead's New Single Tablet HIV Regimen](https://longbridge.com/en/news/297549407.md)
- [Parallax Volatility Advisers L.P. Trims Holdings in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/297162579.md)
- [Gilead breaks ground on Foster City biologics facility in $32 billion US investment push](https://longbridge.com/en/news/297254548.md)
- [FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients](https://longbridge.com/en/news/297236507.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**